Our Monthly Scientific Selection: February Publications on EuroQol Instruments

[1-29 February 2024]

1. Lipman SA, Reckers-Droog VT. Comparing heuristic valuation processes between health state valuation from child and adult perspectives. Eur J Health Econ. 2024 Feb 3.

2. O’Loughlin R, Jones R, Chen G, Mulhern B, Hiscock H, Devlin N, Dalziel K. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression. Pharmacoeconomics. 2024 Feb 8.

3. Al-Jedai A, Almudaiheem H, Al-Salamah T, Aldosari M, Almutairi AR, Almogbel Y, AlRuthia Y, Althemery AU, Alluhidan M, Roudijk B, Purba FD, Awad N, O’jeil R. Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A national representative study. Value Health. 2024 Feb 9.

4. Zhou W, Shen A, Yang Z, Wang P, Wu B, Herdman M, Busschbach J, Luo N. Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers. Eur J Health Econ. 2024 Feb 14.

5. Feng YS, Kohlmann T, Peasgood T, Engel L, Mulhern B, Pickard AS. Scoring the EQ-HWB-S: can we do it without value sets? A non-parametric item response theory analysis. Qual Life Res. 2024 Feb 21.

6. Nikl A, Janssen MF, Jenei B, Brodszky V, Rencz F. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary. Pharmacoeconomics. 2024 Feb 28.